CA Patent

CA2320772A1 — High-energy cyclodextrin complexes

Assigned to Cyclops hf · Expires 1999-08-26 · 27y expired

What this patent protects

Methods for enhancing the complexation efficiency of a drug with cyclodextrin and for enhancing the availability of a drug following administration of a cyclodextrin-drug complex.

USPTO Abstract

Methods for enhancing the complexation efficiency of a drug with cyclodextrin and for enhancing the availability of a drug following administration of a cyclodextrin-drug complex.

Drugs covered by this patent

amiodarone-hydrochloride (AMIODARONE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2320772A1
Jurisdiction: CA
Classification: —
Expires: 1999-08-26
Drug substance claim: No
Drug product claim: No
Assignee: Cyclops hf
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.